GRI BIO, INC.: other noncurrent liabilities
Other noncurrent liabilities for GRI BIO, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All GRI BIO, INC. financial histories
What this measure means
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
Exact concept: us-gaap:OtherLiabilitiesNoncurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2020-12-31 to 2022-12-31. The SEC response was captured on 2026-09-21.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2022-12-31 | 0 | USD | 2023-02-24 | 10-K · 0001824293-23-000016 |
| At date | 2021-12-31 | 72,000 | USD | 2023-02-24 | 10-K · 0001824293-23-000016 |
| At date | 2020-12-31 | 170,000 | USD | 2022-02-14 | 10-K · 0001824293-22-000004 |
Related financial histories
- GRI BIO, INC.: total assets
- GRI BIO, INC.: total liabilities
- GRI BIO, INC.: stockholders equity
- GRI BIO, INC.: cash and cash equivalents
- GRI BIO, INC.: net income or loss
- GRI BIO, INC.: operating cash flow
- GRI BIO, INC.: capital expenditure payments
- GRI BIO, INC.: financing cash flow
- GRI BIO, INC.: investing cash flow
- GRI BIO, INC.: retained earnings or deficit
- GRI BIO, INC.: basic weighted-average shares
- GRI BIO, INC.: diluted weighted-average shares
- GRI BIO, INC.: basic earnings per share
- GRI BIO, INC.: diluted earnings per share
- GRI BIO, INC.: net property, plant and equipment
- GRI BIO, INC.: share-based compensation expense
- GRI BIO, INC.: operating income or loss
- GRI BIO, INC.: current assets
- GRI BIO, INC.: current liabilities
- GRI BIO, INC.: current accounts payable
- GRI BIO, INC.: operating expenses
- GRI BIO, INC.: research and development expense
- GRI BIO, INC.: common shares outstanding
- GRI BIO, INC.: cash including restricted cash
- GRI BIO, INC.: accumulated other comprehensive income or loss
- GRI BIO, INC.: operating lease right-of-use asset
- GRI BIO, INC.: operating lease liability
- GRI BIO, INC.: gross property, plant and equipment
- GRI BIO, INC.: accumulated depreciation on property, plant and equipment
- GRI BIO, INC.: other noncurrent assets
- GRI BIO, INC.: accrued current liabilities
- GRI BIO, INC.: prepaid expenses and other current assets
- GRI BIO, INC.: comprehensive income or loss
- GRI BIO, INC.: net income available to common stockholders
- GRI BIO, INC.: general and administrative expense
- GRI BIO, INC.: depreciation expense
- GRI BIO, INC.: other nonoperating income or expense
- GRI BIO, INC.: interest paid, net
- GRI BIO, INC.: operating lease payments
- GRI BIO, INC.: change in accounts payable
Inspect the source
- Entity
- GRI BIO, INC. / CIK 0001824293
- Captured
- 2026-09-21T17:29:33.135Z
- SEC response SHA-256
c15b685556461350fde843ddbac84ff1794255de677256ec9777fe02da26f4a8
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001824293.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))